- Published on
Diagnostic Tests – Aldolase
1. What is it associated with?
Aldolase is an enzyme released from damaged skeletal muscle. It is elevated in inflammatory myopathies, particularly:
2. When do you answer aldolase?
You should choose aldolase (or CPK) as the best initial diagnostic test when the clinical vignette suggests an inflammatory myopathy, such as:
Exam pearl:
Proximal muscle weakness + dermatomyositis rash → check aldolase or CPK first
3. What is the most accurate test?
While aldolase is useful for initial screening, the most accurate diagnostic tests for polymyositis and dermatomyositis are:
1. What is it associated with?
Aldolase is an enzyme released from damaged skeletal muscle. It is elevated in inflammatory myopathies, particularly:
- Polymyositis
- Dermatomyositis
2. When do you answer aldolase?
You should choose aldolase (or CPK) as the best initial diagnostic test when the clinical vignette suggests an inflammatory myopathy, such as:
- An older woman with proximal muscle weakness
- Difficulty rising from a chair or lifting arms
- Associated myalgias
- Characteristic skin findings, including:
- Heliotrope rash
- Gottron’s papules
Exam pearl:
Proximal muscle weakness + dermatomyositis rash → check aldolase or CPK first
3. What is the most accurate test?
While aldolase is useful for initial screening, the most accurate diagnostic tests for polymyositis and dermatomyositis are:
- Electromyography (EMG)
- Muscle biopsy
- Published on
Diagnostic Tests – C-ANCA (Antineutrophil Cytoplasmic Antibody)
1. What is this?
C-ANCA is a serologic test used to diagnose granulomatosis with polyangiitis (GPA), formerly known as Wegener’s granulomatosis. It is the best initial test to make a specific diagnosis of this vasculitic disorder. The antibodies are directed against proteinase-3 (PR3) in neutrophils.
2. How is it done?
C-ANCA is a blood test analyzed using indirect immunofluorescence microscopy. The characteristic cytoplasmic (C-ANCA) staining pattern reflects antibodies targeting PR3, which is highly associated with granulomatosis with polyangiitis.
3. When do you answer C-ANCA?
You should select C-ANCA when a patient presents with a classic triad of involvement:
ENT symptoms + lung disease + renal findings → C-ANCA
4. What is the most accurate diagnostic test?
The most accurate (definitive) diagnostic test for granulomatosis with polyangiitis is a tissue biopsy, typically from:
1. What is this?
C-ANCA is a serologic test used to diagnose granulomatosis with polyangiitis (GPA), formerly known as Wegener’s granulomatosis. It is the best initial test to make a specific diagnosis of this vasculitic disorder. The antibodies are directed against proteinase-3 (PR3) in neutrophils.
2. How is it done?
C-ANCA is a blood test analyzed using indirect immunofluorescence microscopy. The characteristic cytoplasmic (C-ANCA) staining pattern reflects antibodies targeting PR3, which is highly associated with granulomatosis with polyangiitis.
3. When do you answer C-ANCA?
You should select C-ANCA when a patient presents with a classic triad of involvement:
- Upper respiratory tract disease: chronic sinusitis, otitis media
- Lower respiratory tract disease: cough, hemoptysis, sputum production, abnormal chest X-ray not responsive to antibiotics
- Renal disease: hematuria, red blood cell casts
ENT symptoms + lung disease + renal findings → C-ANCA
4. What is the most accurate diagnostic test?
The most accurate (definitive) diagnostic test for granulomatosis with polyangiitis is a tissue biopsy, typically from:
- Lung, or
- Kidney
- Published on
Diagnostic Tests – Anti–Scl-70 (Anti–Topoisomerase I) Antibodies
1. What is this?
Anti–Scl-70 antibodies are autoantibodies directed against topoisomerase I, a nuclear enzyme. They are associated with systemic sclerosis, particularly the diffuse cutaneous form. Their presence supports the diagnosis and helps with risk stratification.
2. When do you answer anti–Scl-70 antibodies?
Order anti–Scl-70 when the clinical picture suggests diffuse systemic sclerosis, such as:
Exam pearl: Diffuse scleroderma features → think anti–Scl-70.
3. How would a negative test affect management?
A negative anti–Scl-70 does not rule out systemic sclerosis because the test has low sensitivity (~30%).
If clinical suspicion remains high, management and further evaluation should continue despite a negative result.
4. What is the patient at risk for if anti–Scl-70 is positive?
A positive anti–Scl-70 is most strongly associated with severe pulmonary involvement, especially:
This finding signals a higher-risk disease course and warrants close pulmonary monitoring.
High-yield contrast
1. What is this?
Anti–Scl-70 antibodies are autoantibodies directed against topoisomerase I, a nuclear enzyme. They are associated with systemic sclerosis, particularly the diffuse cutaneous form. Their presence supports the diagnosis and helps with risk stratification.
2. When do you answer anti–Scl-70 antibodies?
Order anti–Scl-70 when the clinical picture suggests diffuse systemic sclerosis, such as:
- Polyarthralgia
- Raynaud phenomenon
- Thick, tight (“hide-bound”) skin
- Dysphagia and GI hypomotility
- Evidence of pulmonary and/or renal involvement
Exam pearl: Diffuse scleroderma features → think anti–Scl-70.
3. How would a negative test affect management?
A negative anti–Scl-70 does not rule out systemic sclerosis because the test has low sensitivity (~30%).
If clinical suspicion remains high, management and further evaluation should continue despite a negative result.
4. What is the patient at risk for if anti–Scl-70 is positive?
A positive anti–Scl-70 is most strongly associated with severe pulmonary involvement, especially:
- Interstitial lung disease
- Pulmonary fibrosis
This finding signals a higher-risk disease course and warrants close pulmonary monitoring.
High-yield contrast
- Limited systemic sclerosis (CREST) → Anticentromere antibodies
- Diffuse systemic sclerosis → Anti–Scl-70 antibodies
- Published on
Diagnostic Tests – Anti-Ro (SSA) and Anti-La (SSB) Antibodies
1. What diseases are they associated with?
Anti-Ro (SSA) and Anti-La (SSB) antibodies are most strongly associated with Sjögren’s syndrome. Patients with Sjögren’s syndrome classically have:
These antibodies may also be seen in other connective tissue diseases, but their strongest association is with Sjögren’s syndrome.
2. When are they the answer?
You should select anti-Ro and anti-La antibody testing when the clinical scenario describes the classic sicca triad, which includes:
Dry eyes + dry mouth + arthritis → think Sjögren’s syndrome → order anti-Ro / anti-La antibodies.
1. What diseases are they associated with?
Anti-Ro (SSA) and Anti-La (SSB) antibodies are most strongly associated with Sjögren’s syndrome. Patients with Sjögren’s syndrome classically have:
- Positive ANA
- Anti-Ro and/or Anti-La antibodies
- Often a positive rheumatoid factor
These antibodies may also be seen in other connective tissue diseases, but their strongest association is with Sjögren’s syndrome.
2. When are they the answer?
You should select anti-Ro and anti-La antibody testing when the clinical scenario describes the classic sicca triad, which includes:
- Dry eyes (keratoconjunctivitis sicca)
- Dry mouth (xerostomia)
- Arthritis or arthralgias
Dry eyes + dry mouth + arthritis → think Sjögren’s syndrome → order anti-Ro / anti-La antibodies.
- Published on
Diagnostic Tests – Fungal Culture
1. For which clinical scenario(s) is this the best (most accurate) test?
A fungal culture is the most accurate confirmatory test for superficial fungal infections, including:
It allows definitive identification of the fungal organism and is especially useful when the diagnosis is uncertain or treatment has failed.
2. When is this test the best initial step?
Never.
Although fungal culture is highly accurate, it is not the best initial diagnostic test. Superficial fungal infections are primarily diagnosed by:
3. What is the management?
Treatment depends on the location of the fungal infection:
Suspected fungal infection → KOH prep first
Need definitive identification or refractory case → Fungal culture
1. For which clinical scenario(s) is this the best (most accurate) test?
A fungal culture is the most accurate confirmatory test for superficial fungal infections, including:
- Tinea infections (corporis, cruris, pedis)
- Onychomycosis (nail infections)
- Fungal vaginitis
It allows definitive identification of the fungal organism and is especially useful when the diagnosis is uncertain or treatment has failed.
2. When is this test the best initial step?
Never.
Although fungal culture is highly accurate, it is not the best initial diagnostic test. Superficial fungal infections are primarily diagnosed by:
- Clinical appearance
- KOH preparation (to visualize hyphae or yeast)
3. What is the management?
Treatment depends on the location of the fungal infection:
- Require oral antifungals:
- Onychomycosis
- Tinea capitis
- Medications: terbinafine or itraconazole
- Treated with topical antifungals:
- Most other cutaneous fungal infections
- Medications: ketoconazole, clotrimazole, nystatin, ciclopirox
Suspected fungal infection → KOH prep first
Need definitive identification or refractory case → Fungal culture
- Published on
Diagnostic Tests – 17-Hydroxyprogesterone Level
1. What is this test?
The 17-hydroxyprogesterone (17-OHP) level is a screening blood test used to diagnose congenital adrenal hyperplasia (CAH), most commonly due to 21-hydroxylase deficiency. In this condition, impaired cortisol synthesis leads to accumulation of 17-hydroxyprogesterone, which is shunted into androgen production.
2. When do you answer it?
You should select a 17-hydroxyprogesterone level when the clinical scenario suggests excess androgen production or impaired adrenal steroid synthesis, including:
In exam settings, these presentations strongly point toward 21-hydroxylase deficiency, making 17-hydroxyprogesterone the best initial diagnostic test.
1. What is this test?
The 17-hydroxyprogesterone (17-OHP) level is a screening blood test used to diagnose congenital adrenal hyperplasia (CAH), most commonly due to 21-hydroxylase deficiency. In this condition, impaired cortisol synthesis leads to accumulation of 17-hydroxyprogesterone, which is shunted into androgen production.
2. When do you answer it?
You should select a 17-hydroxyprogesterone level when the clinical scenario suggests excess androgen production or impaired adrenal steroid synthesis, including:
- Female infant with ambiguous genitalia (simple virilizing form)
- Infant with hyponatremia, hyperkalemia, and hypotension (salt-wasting crisis)
- Young woman with hirsutism, acne, and irregular menses
- Child with precocious puberty
In exam settings, these presentations strongly point toward 21-hydroxylase deficiency, making 17-hydroxyprogesterone the best initial diagnostic test.
- Published on
Diagnostic Tests – Diascopy
1. For which clinical condition(s) is this test commonly used?
Diascopy is a simple bedside test used in dermatology for the initial evaluation of erythematous skin lesions. It helps determine whether skin redness is due to vasodilation or extravasation of red blood cells from damaged blood vessels. The test is performed by pressing a clear glass or plastic slide against the lesion.
2. What do you look for?
During diascopy, you observe whether the lesion blanches (turns white) when pressure is applied:
This distinction is clinically important, as non-blanching lesions often suggest more serious underlying pathology requiring further investigation.
1. For which clinical condition(s) is this test commonly used?
Diascopy is a simple bedside test used in dermatology for the initial evaluation of erythematous skin lesions. It helps determine whether skin redness is due to vasodilation or extravasation of red blood cells from damaged blood vessels. The test is performed by pressing a clear glass or plastic slide against the lesion.
2. What do you look for?
During diascopy, you observe whether the lesion blanches (turns white) when pressure is applied:
- Blanching lesion
→ Indicates vasodilation
→ Common in viral exanthems, drug reactions, and insect bites - Non-blanching lesion
→ Indicates extravasation of erythrocytes due to vascular damage
→ Seen in vasculitic and purpuric conditions
This distinction is clinically important, as non-blanching lesions often suggest more serious underlying pathology requiring further investigation.
- Published on
Diagnostic Tests – Fine-Needle Aspiration (FNA) of the Thyroid
1. What is this test?
Fine-needle aspiration (FNA) of the thyroid is a minimally invasive procedure in which a thin needle is used to obtain a sample of thyroid cells for cytologic examination. It is the initial diagnostic test of choice for most solitary thyroid nodules, as it helps determine whether a nodule is benign or malignant.
2. When is this the most accurate test?
FNA is the most appropriate and accurate next step when a patient has:
In exam questions, if a euthyroid patient with a thyroid nodule is described and the question asks for the next step in diagnosis, the correct answer is typically fine-needle aspiration.
3. When is this the wrong answer?
FNA is not the correct initial test in patients with a solitary thyroid nodule who are thyrotoxic (suppressed TSH, elevated T3/T4). In this scenario, a thyroid scintigraphy (radioiodine uptake scan) should be performed first to determine whether the nodule is:
1. What is this test?
Fine-needle aspiration (FNA) of the thyroid is a minimally invasive procedure in which a thin needle is used to obtain a sample of thyroid cells for cytologic examination. It is the initial diagnostic test of choice for most solitary thyroid nodules, as it helps determine whether a nodule is benign or malignant.
2. When is this the most accurate test?
FNA is the most appropriate and accurate next step when a patient has:
- A palpable solitary thyroid nodule
- Normal thyroid function tests (euthyroid state)
In exam questions, if a euthyroid patient with a thyroid nodule is described and the question asks for the next step in diagnosis, the correct answer is typically fine-needle aspiration.
3. When is this the wrong answer?
FNA is not the correct initial test in patients with a solitary thyroid nodule who are thyrotoxic (suppressed TSH, elevated T3/T4). In this scenario, a thyroid scintigraphy (radioiodine uptake scan) should be performed first to determine whether the nodule is:
- Hyperfunctioning (“hot”) — almost never malignant
- Hypofunctioning (“cold”) — higher risk of malignancy and may then require FNA
- Published on
Diagnostic Tests – Progesterone Challenge Test
1. For which clinical scenario(s) is this the best test?
The progesterone challenge test is used in the evaluation of amenorrhea after pregnancy has been excluded with a negative hCG test. It is most appropriate for a woman who has absent menstrual periods and helps determine whether amenorrhea is due to outflow tract obstruction or dysfunction at the level of the hypothalamus or pituitary. The test typically involves administering oral progesterone (about 10 mg daily for 5 days).
2. If bleeding occurs after the challenge, what does it indicate?
If withdrawal bleeding occurs, this indicates that:
This finding suggests that the amenorrhea is not due to an anatomic obstruction.
3. What is the next best test if bleeding occurs?
If bleeding occurs, the next step is to evaluate for hypothalamic or pituitary causes of amenorrhea. This is done by checking:
These tests help identify endocrine disorders such as hyperprolactinemia, hypothyroidism, or gonadotropin abnormalities.
4. If there is no bleeding, what is the next best test?
If no withdrawal bleeding occurs, this suggests either insufficient estrogen or an outflow tract obstruction. The next best step is to evaluate the reproductive anatomy, starting with pelvic ultrasound. If ultrasound findings are inconclusive, MRI is used to further assess for structural abnormalities or obstruction of the uterine outflow tract.
1. For which clinical scenario(s) is this the best test?
The progesterone challenge test is used in the evaluation of amenorrhea after pregnancy has been excluded with a negative hCG test. It is most appropriate for a woman who has absent menstrual periods and helps determine whether amenorrhea is due to outflow tract obstruction or dysfunction at the level of the hypothalamus or pituitary. The test typically involves administering oral progesterone (about 10 mg daily for 5 days).
2. If bleeding occurs after the challenge, what does it indicate?
If withdrawal bleeding occurs, this indicates that:
- Estrogen levels are adequate to build up the endometrial lining
- The uterus and outflow tract are intact and patent
This finding suggests that the amenorrhea is not due to an anatomic obstruction.
3. What is the next best test if bleeding occurs?
If bleeding occurs, the next step is to evaluate for hypothalamic or pituitary causes of amenorrhea. This is done by checking:
- FSH
- LH
- Prolactin
- TSH
These tests help identify endocrine disorders such as hyperprolactinemia, hypothyroidism, or gonadotropin abnormalities.
4. If there is no bleeding, what is the next best test?
If no withdrawal bleeding occurs, this suggests either insufficient estrogen or an outflow tract obstruction. The next best step is to evaluate the reproductive anatomy, starting with pelvic ultrasound. If ultrasound findings are inconclusive, MRI is used to further assess for structural abnormalities or obstruction of the uterine outflow tract.
- Published on
Diagnostic Tests – Excision Skin Biopsy
1. For which clinical scenario(s) is this diagnostic tool indicated?
An excision skin biopsy is a diagnostic technique in which the entire skin lesion is removed with full thickness, ideally in one intact specimen. It is indicated when there is high clinical suspicion for malignancy, particularly when accurate assessment of lesion depth, margins, and architecture is required for diagnosis and staging.
2. For which condition is this test always the right answer?
An excision biopsy is always the correct diagnostic test for suspected malignant melanoma. Melanoma requires complete removal of the lesion to allow proper evaluation of Breslow depth, which is critical for staging and prognosis. Partial biopsies (such as shave or punch biopsies) are inadequate because they may prevent accurate staging and risk underestimating tumor depth.
Key exam pearl: If melanoma is suspected, excision biopsy is the answer—always.
1. For which clinical scenario(s) is this diagnostic tool indicated?
An excision skin biopsy is a diagnostic technique in which the entire skin lesion is removed with full thickness, ideally in one intact specimen. It is indicated when there is high clinical suspicion for malignancy, particularly when accurate assessment of lesion depth, margins, and architecture is required for diagnosis and staging.
2. For which condition is this test always the right answer?
An excision biopsy is always the correct diagnostic test for suspected malignant melanoma. Melanoma requires complete removal of the lesion to allow proper evaluation of Breslow depth, which is critical for staging and prognosis. Partial biopsies (such as shave or punch biopsies) are inadequate because they may prevent accurate staging and risk underestimating tumor depth.
Key exam pearl: If melanoma is suspected, excision biopsy is the answer—always.
